chemie.pr-Bankkaufmann - News
Isotechnika to Hold Conference Call to Discuss Positive PROMISE Trial.03.06.2008 a conference call to discuss final Phase 2b PROMISE kidneytransplant data
Isotechnika to Hold Conference Call to Discuss Positive PROMISE Trial
03.06.2008 13:40:05
Isotechnika Inc.: Edmonton, Canada (ots/PRNewswire) - Isotechnika Inc. will hold a conference call to discuss final Phase 2b PROMISE kidney transplant data for the Company's lead immunosuppressive drug, voclosporin, on Wednesday, June 4th at 9:00 a.m. ET/7:00 a.m. MT. As previously announced, the final Phase 2b kidney transplant trial (PROMISE) results will be presented during an oral presentation by Dr. Osama Gaber, Director of Transplantation, ...
Lesen Sie hier weiter... |
Drucken |
PDF
Ähnliche Artikel
- Isotechnika Reports Final Results of the PROMISE Trial
- Isotechnika Presents Positive Data From the Promise Trial of Voclosporin at the American Transplant Congress
- Drug-Eluting Coronary Stents Utilizing Isotechnika's Lead Drug Receive Approval to Enter Clinical Trials
- Movetis' Second Most Advanced Product Progresses to Phase IIb Trial Following Positive Results in Cirrhotic Ascites
- Pertuzumab With Herceptin(R) Shows Impressive Results in Women With Advanced HER2-Positive Breast Cancer
- Herceptin(R) Helps Eradicate HER2-Positive Breast Tumours When Given Before Surgery
- Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe
- Almirall and Forest Laboratories Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel Long-Acting Anticholinergic for the Treatment for COPD
- First Landmark ARB Trial Against Placebo Shows MICARDIS(R) (Telmisartan) Reduces the Risk of Cardiovascular Death, Heart Attack and Stroke in ACE-Intolerant High-Risk Patients(1)
- Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
www.finanznachrichten.de/nachrichten-aktien/<b>isotechnika</b>-de.asp
Congress :: Isotechnika to Hold Conference Call to Discuss Positive PROMISE Benutzername: Passwort: 3.ISOTECHNIKA.Wie bewerten Sie die aktuell
ots.at: das APA-OTS-Portal für multimediale Presseaussendungen
Isotechnika Presents Positive Data From the Promise Trial of Isotechnika to Hold Conference Call to Discuss Positive PROMISE Trial = 03.06.2008 / 13:06
MedCrawler.de - Die Suchmaschine für Medizin und Gesundheit
MedCrawler.de - Die Suchmaschine für Medizin und Gesundheit - indiziert Isotechnika to Hold Conference Call to Discuss Positive PROMISE Trial
Isotechnika Inc. Aktien | 934786 | CA4649041015 | IKA
Isotechnika Inc.- Isotechnika to Hold Conference Call to Discuss P Isotechnika to hold conference call to discuss positive PROMISE trial.CNX Marketlink